| __timestamp | ImmunityBio, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 5280000 |
| Thursday, January 1, 2015 | 11434000 | 7148000 |
| Friday, January 1, 2016 | 26546000 | 19594000 |
| Sunday, January 1, 2017 | 39778000 | 22894000 |
| Monday, January 1, 2018 | 53418000 | 50337000 |
| Tuesday, January 1, 2019 | 111997000 | 109450000 |
| Wednesday, January 1, 2020 | 139507000 | 90450000 |
| Friday, January 1, 2021 | 195958000 | 104128000 |
| Saturday, January 1, 2022 | 248149000 | 108630000 |
| Sunday, January 1, 2023 | 232366000 | 134951000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Rhythm Pharmaceuticals, Inc. and ImmunityBio, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical breakthroughs.
From 2014 to 2023, ImmunityBio, Inc. increased its R&D spending by an impressive 14,500%, peaking in 2022. Meanwhile, Rhythm Pharmaceuticals, Inc. saw a substantial rise of over 2,500% in the same period, with its highest expenditure in 2023. This trend underscores the growing emphasis on developing novel therapies and treatments.
The data reveals a strategic focus on innovation, with both companies consistently allocating a significant portion of their resources to R&D. As the biotech industry continues to evolve, these investments are likely to play a pivotal role in shaping the future of healthcare.
Research and Development Expenses Breakdown: Novartis AG vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Amgen Inc. and Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
Analyzing R&D Budgets: Opthea Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.